Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debabrata Banerjee

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|April 9, 2005
Identification of amino acids required for the functional up-regulation of human dihydrofolate reductase protein in response to antifolate TreatmentNancy Skacel, Lata G Menon, Prasunkumar J Mishra, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2007
A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistancePrasun J Mishra, Rita Humeniuk, Pravin J Mishra, et al.
Scandinavian Journal of Gastroenterology|December 2, 2008
High frequency of parasitic and viral stool pathogens in patients with active ulcerative colitis: report from a tropical countryDebabrata Banerjee, Rachana Deb, Lalit Dar, et al.
Experimental Cell Research|December 20, 2011
Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironmentYanique I Rattigan, Brijesh B Patel, Ellen Ackerstaff, et al.
Cancer Biology & Therapy|February 17, 2012
Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximabNora M Barboza, Daniel J Medina, Tulin Budak-Alpdogan, et al.
Molecular Pharmacology|July 3, 2009
Species-specific differences in translational regulation of dihydrofolate reductaseYi-Ching Hsieh, Nancy E Skacel, Nitu Bansal, et al.
Experimental Cell Research|January 31, 2017
Tumor stroma interaction is mediated by monocarboxylate metabolismBrijesh B Patel, Ellen Ackerstaff, Inna S Serganova, et al.
Cancer Gene Therapy|September 11, 2004
Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion geneGina M Capiaux, Tulin Budak-Alpdogan, Onder Alpdogan, et al.
Cancer Biology & Therapy|October 9, 2007
Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancerKiranmayi Tadi, Badithe T Ashok, Yuangen Chen, et al.
Anti-Cancer Drugs|December 13, 2006
Preclinical toxicological examination of a putative prostate cancer-specific 4-methyl-1-nitroacridine derivative in rodentsBadithe T Ashok, Kiranmayi Tadi, Venkata P S Garikapaty, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|April 9, 2005
Identification of amino acids required for the functional up-regulation of human dihydrofolate reductase protein in response to antifolate TreatmentNancy Skacel, Lata G Menon, Prasunkumar J Mishra, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2007
A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistancePrasun J Mishra, Rita Humeniuk, Pravin J Mishra, et al.
Scandinavian Journal of Gastroenterology|December 2, 2008
High frequency of parasitic and viral stool pathogens in patients with active ulcerative colitis: report from a tropical countryDebabrata Banerjee, Rachana Deb, Lalit Dar, et al.
Experimental Cell Research|December 20, 2011
Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironmentYanique I Rattigan, Brijesh B Patel, Ellen Ackerstaff, et al.
Cancer Biology & Therapy|February 17, 2012
Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximabNora M Barboza, Daniel J Medina, Tulin Budak-Alpdogan, et al.
Molecular Pharmacology|July 3, 2009
Species-specific differences in translational regulation of dihydrofolate reductaseYi-Ching Hsieh, Nancy E Skacel, Nitu Bansal, et al.
Experimental Cell Research|January 31, 2017
Tumor stroma interaction is mediated by monocarboxylate metabolismBrijesh B Patel, Ellen Ackerstaff, Inna S Serganova, et al.
Cancer Gene Therapy|September 11, 2004
Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion geneGina M Capiaux, Tulin Budak-Alpdogan, Onder Alpdogan, et al.
Cancer Biology & Therapy|October 9, 2007
Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancerKiranmayi Tadi, Badithe T Ashok, Yuangen Chen, et al.
Anti-Cancer Drugs|December 13, 2006
Preclinical toxicological examination of a putative prostate cancer-specific 4-methyl-1-nitroacridine derivative in rodentsBadithe T Ashok, Kiranmayi Tadi, Venkata P S Garikapaty, et al.
Pageof 10